Various mesenchymal cell types have been identified as critical components of the hematopoietic stem/progenitor cell (HSPC) niche. Although several groups have described the generation of mesenchyme from human pluripotent stem cells (hPSCs), the capacity of such cells to support hematopoiesis has not been reported. Here, we demonstrate that distinct mesenchymal subpopulations co-emerge from mesoderm during hPSC differentiation. Despite co-expression of common mesenchymal markers (CD73, CD105, CD90, and PDGFRb), a subset of cells defined as CD146 
INTRODUCTION
Maintenance of bona fide self-renewing hematopoietic stem and progenitor cells (HSPCs) ex vivo remains challenging in part because of our limited ability to recapitulate the human HSPC niche in culture. Intensive research efforts have begun to uncover the cellular and molecular constituents of the niche that regulate self-renewal and differentiation of HSPCs. Through the use of knockout and transgenic mice, several cell populations have been described in terms of their spatial relationship to the bone and blood vessels of the bone marrow, and their differential expression of various markers and bioactive molecules (Ding et al., 2012; Itkin et al., 2016; Kobayashi et al., 2010; Kunisaki et al., 2013) .
High expression of melanoma-associated cell adhesion molecule (CD146) identifies human pericytes, a cell type that ensheaths capillaries, venules, arterioles, and sinusoids (Crisan et al., 2008) and can establish a heterotopic hematopoietic stem cell (HSC) niche when transplanted into immunodeficient mice (Sacchetti et al., 2007) . Unlike CD146 À mesenchyme, monolayers of CD146 ++ cells isolated from primary tissue (adult adipose tissue and fetal bone marrow) can support human HSPCs co-cultured for at least 2 weeks in the absence of exogenous cytokines (Corselli et al., 2013) . We and others have shown that mesenchymal cells can be differentiated from human pluripotent stem cells (hPSCs) (Chin et al., 2016; Ferrell et al., 2014; Hoffman and Calvi, 2014; Vodyanik et al., 2010) . These previous studies identified mesenchyme as a single population defined mostly by expression of CD73 and/or CD105 and absence of hematopoietic and endothelial markers. We now report that the mesenchyme generated from hPSCs is functionally and transcriptionally heterogeneous. Our studies identified a distinct subpopulation of hPSC-derived mesenchyme that expressed high levels of CD146 and CD73 and low levels of PDGFRa (CD140a) and that was capable of supporting clonogenic, engraftable, and self-renewing human HSPCs ex vivo without exogenous cytokines. In contrast CD146 lo CD73 lo mesenchyme showed significantly less capacity to support HSPCs. Transcriptome analysis revealed that the CD146 hi CD73 hi cells expressed significantly higher levels than CD146 lo CD73 lo cells of perivascular markers and niche factors known to have critical roles in HSC maintenance. HSPC support was dependent in part on cell-cell interactions and Notch signaling through stromal expression of JAG1, whereas differentiation was promoted by WNT signaling. Closer transcriptional analysis, combining data from mesenchyme generated from hPSCs and human primary tissue, revealed that dominant pathways shared by the CD146 ++ populations were those related to vascular development, cell adhesion, and motility. Our data suggest that hPSCderived mesoderm can generate mesenchymal cells phenotypically, functionally, and molecularly, similar to previously identified primary pericytes that contribute to the human HSPC niche.
RESULTS

Heterogeneity of Embryonic Mesoderm-Derived Mesenchymal Cells
We have previously characterized a human embryonic mesoderm progenitor (hEMP) population derived from hPSCs that marks the onset of mesoderm commitment and has the potential to generate a broad range of mesodermal derivatives, including mesenchyme, endothelium, and bone, three lineages that play a crucial role in the hematopoietic niche (Chin et al., 2016; Hoffman and Calvi, 2014) . hEMPs were isolated at day 3.5 of mesoderm differentiation from H1 embryonic stem cells (Evseenko et al., 2010 ) ( Figure 1A ), and recultured using conditions that favor mesenchymal differentiation. After a further 14 days, cultures contained a mixture of CD31 + CD45
À endothelial cells and CD31 À CD45 À mesenchymal cells. The mesenchymal cells consisted of at least two populations that could be discriminated based on expression of CD146, CD73, and CD140a (PDGFRa) ( Figure 1A ). High co-expression of CD146 and CD73 identified a largely CD140a À population, whereas CD146 lo cells expressed intermediate levels of CD73 and high levels of CD140a. This inverse expression pattern between CD146 and CD140a was consistent with mesenchyme derived from primary human lipoaspirates ( Figure S1A ). Despite the differential expression of CD146, CD73, and CD140a, both hPSC-derived mesenchymal subsets expressed classic mesenchymal markers CD90, CD105, CD44, and PDGFRb ( Figure S1B ). Mesenchymal differentiation from two other hPSC lines, UCLA3 and UCLA6, yielded similar populations to the H1 line, with an inverse relationship of CD146 and CD73 to CD140a expression ( Figures S2A and S2B ). Although few CD146 hi CD73 hi cells were present early in differentiation (days 4-5), the inverse expression pattern of CD146 and CD73 to CD140a was present throughout mesenchymal differentiation ( Figure S2C ). To better understand whether the phenotypes above identified distinct mesenchymal cell types, we focused our studies on cells that represented the extremes of these phenotypes: a CD146 hi CD73 hi population and a CD146 lo CD73 lo population ( Figure 1A ). Bromode- Figure 1C) . Across all hESC lines tested, CD146 hi CD73 hi mesenchyme expressed significantly higher levels of pericyte markers CSPG4 (which encodes NG2), NES (NESTIN), LEPR (leptin receptor), and the b2-adrenergic receptor ADRB2 (Crisan et al., 2008; Hoffman and Calvi, 2014; Kunisaki et al., 2013) , and HSC regulatory genes, KITLG, IGFBP2, and TNC (Ding et al., 2012; Huynh et al., 2008; Nakamura-Ishizu et al., 2012; Zhang et al., 2008) ( Figures  1C, S1C , S2A, and S2B). In contrast, the CD146 lo CD73 lo mesenchyme expressed significantly higher levels of the niche factors CXCL12 and ADRB3 (Greenbaum et al., 2013; Méndez-Ferrer et al., 2008 ) ( Figure 1C ). Expression of extracellular matrix genes was upregulated after the hEMP stage in both mesenchymal phenotypes ( Figure 1C ). Figure 2G ). Of note, multiple other hPSC-derived phenotypic subsets were screened based on their CD146 and CD140a expression; irrespective of CD140a expression, those subsets with high levels of CD146 best supported HSPCs ( Figure S3A ). When Lin À CD34 + CD38 À cells, a more primitive HSCenriched population were studied, the co-culture system was modified by adding exogenous growth factors to allow sufficient cell growth for analysis. In the presence of cytokines, both mesenchymal populations were able to support CD34 + cells for 2-4 weeks. However, only the CD146 hi CD73 hi mesenchyme could maintain
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HSCs (n = 4, p < 0.05), and CD34 + CD33 À cells ( Figure S3B ), demonstrating again the functional differences between the two mesenchymal populations in HSPC support. hi and CD146 lo CD73 lo mesenchyme (as in Figure 1A ). Relative expression shown for each gene using its min/max moderate expression estimates as reference. n = 3 biological replicates. Error bars represent SEM. See also Figures S1 and S2. Notch signaling is a well-established cell contact-dependent paracrine factor and deletion of Jagged1 (encoded by Jag1) results in premature exhaustion of the murine HSC pool (Poulos et al., 2013 Figure 3C ). Addition of a neutralizing antibody to human JAG1 caused a profound (>300-fold) decrease in the number of CD34 + Lin À cells in CD146 hi CD73 hi co-cultures (p % 0.05, n = 3) and 250-fold decrease in CD146 lo CD73 lo co-cultures (Figure 3D) . Of note, cell output was not significantly reduced when anti-JAG1 was added to co-cultures on OP9, a mouse stromal cell line, thus excluding non-specific cytotoxicity from the blocking antibody ( Figure S4A lo . (J) Engraftment (percent of human cells) of mice 6 weeks after primary and secondary transplants (n = 5 independent experiments, total 9-14 mice per group; ***p <.0001; ns, not significant). Error bars represent SEM. See also Figure S3 . Figure 3G ). This latter observation is consistent with previous findings that canonical Wnt signaling regulates hematopoiesis in a dosage-dependent fashion, with high Wnt activation detrimental to HSC self-renewal leading to depletion of the LT-HSC pool (Famili et al., 2016; Luis et al., 2011) . It is possible that functional redundancy among Wnt inhibitors obscures the impact of manipulating expression of single factors such as SFRP1 on HSPC support during co-culture. + Lin À , myeloid and lymphoid cell numbers after activation of Wnt signaling by addition of 3 mM CHIR99021 (*p < 0.05, **p < 0.01, ***p < 0.001; ns, not significant; n = 3 independent experiments). Error bars represent SEM. See also Figure S4 . Principal-component analysis showed that the populations clustered mostly based on source rather than immunophenotype (data not shown). Similar observations that tissue-imprinted genes constitute major variances in unsupervised analysis have been reported in other comparative studies (Charbord et al., 2014) . To uncover shared functional gene sets across stromal lines with HSPC-supportive capacity, we performed gene set enrichment analysis (Subramanian et al., 2005) Figure 4A , enrichment score of 1.36 and 1.78 in fresh and cultured pericytes respectively). Similarly, the negative signatures of hPSC-CD146 hi CD73 hi cells were significantly enriched in genes highly downregulated in primary pericytes ( Figure 4B , enrichment score of À1.77 and À1.39). Thus hPSC-and adipose-derived CD146 hi CD73 hi cells exhibited similar transcriptional signatures. The shared core transcriptional signature obtained from both hPSC-and adipose-derived CD146 ++ cells (104 genes, Table S1 ) was imported into the STRING database to identify known and predicted protein interactions (STRING protein-protein interaction enrichment p <10 3 10 À12 )
( Figure 4C ). Of note, the dominant functional categories identified in the STRING analysis were those enriched in biological processes characteristic of pericytes, i.e., cell adhesion (FDR < 6 3 10 À6 ), vasculature development (FDR < 7 3 10 À8 ), regulation of cell motion (FDR < 3 3 10 À8 ), and wound healing (FDR < 3 3 10 À4 ), among others ( Figure 4C ). Therefore, the shared transcriptional signature between hPSC-and adipose-derived CD146 ++ cells is significantly enriched in processes involved in niche homeostasis and maintenance.
DISCUSSION
Mesenchymal stromal/stem cells, either derived from primary tissues or differentiated from hPSC, are conventionally isolated and expanded as a population of cells loosely defined by CD73, CD105, and CD90 expression (Murray et al., 2014) . Our data strongly argue that phenotypically, molecularly, and functionally distinct populations coexist within these conventional definitions of mesenchymal stroma. Previously, CD146 was shown to define mesenchymal precursors adjacent to the vasculature of multiple human organs, including bone marrow and adipose tissues (Crisan et al., 2009 ). Other studies have derived CD146 + pericytes from hPSCs, demonstrating the capacity of these cells to reconstruct a vascular network (Dar et al., 2012; Kusuma et al., 2013; Orlova et al., 2014) . Our previous work (Corselli et al., 2013) identified immunophenotypic subsets of mesenchyme isolated from human primary tissues and found that a subpopulation of perivascular mesenchyme with high expression of CD146 possessed significantly greater HSPC supporting ability. In the current paper, we show that two phenotypically, functionally, and molecularly distinct mesenchymal populations can be faithfully recapitulated in the hPSC system. We also provide the transcriptome profiling of these mesenchymal populations, revealing the HSPCsupportive CD146 hi CD73 hi cells to be closely related to primary pericytes. hPSC-derived CD146 hi CD73 hi mesenchyme showed high expression of NES, LEPR, and CSPG4, markers of peri-sinusoidal and peri-arteriolar cells in the murine HSC niche (Ding et al., 2012; Kunisaki et al., 2013; Méndez-Ferrer et al., 2010; Zhou et al., 2014) . The relevance of these perivascular cells has recently been addressed in the context of human hematopoiesis (Corselli et al., 2013; Pinho et al., 2013) . PDGFRa/ CD140a, which is a long-known marker for murine mesenchymal stromal cells (MSCs), was also reported on human fetal bone marrow MSCs capable of supporting HSPC expansion . In contrast, later studies using adult human bone marrow reported that MSCs with hematopoiesis-supporting ability were highly enriched within the CD140a lo/À population but not in CD140a + cells (Li et al., 2014) . These conflicting results may be explained by reports of human mesenchymal stroma, including our own (Corselli et al., 2013) , which suggest that CD140a expression is differentially regulated both developmentally and across tissue types. A recent report demonstrated that nestin + mesenchyme in the murine fetal liver HSC niche expressed CD146 (Khan et al., 2016) , further supporting the inclusion of CD146 in defining mesenchyme with HSC niche activity. In the present study, both CD146 lo cells showed that they could each be distinguished early during mesenchymal differentiation. However, clonal data are needed to understand the developmental relationships of these cell types. It should also be acknowledged that it remains unclear whether the phenotypes examined in our study represent cell types at the extremes of a functional spectrum.
The identification of distinct mesenchymal subsets generated from hPSCs provides a foundation from which developmental and functional differences can be further defined, and the application of each population for cell therapy explored. The ability to prospectively isolate human stroma with HSC-supporting capacity is + compared with lipoaspirate-CD146 À cells. Genes in the core enrichment set are highlighted (shaded gray boxes) and selected genes in this core enrichment set are shown. (C) Up-and downregulated genes common to the core sets of CD146 hi from hPSC and fresh and cultured primary CD146 + cells were imported into the STRING database, which identified a network of known protein-protein interactions (enrichment p value = 0), along with a number of high-confidence (score > 0.9999) predicted interactions. Line thickness is proportional to the confidence level of each interaction. See also Table S1 .
particularly relevant given clinical interest in using stroma co-culture as a platform for HSC expansion (Hofmeister et al., 2007) .
While this study focused on defining cellular subsets within hPSC-derived mesenchyme that would support a well-characterized HSPC population, the existence of distinct mesenchymal subsets during hPSC differentiation has broader implication for the directed differentiation of hPSCs toward definitive, functional HSCs. Further study will be needed to define the optimal hPSC-derived mesenchyme that would promote HSC specification.
EXPERIMENTAL PROCEDURES
Mesoderm Differentiation from hPSCs to Generate hEMPs
The hPSC lines H1 (WiCell, Madison, WI), and UCLA3 and UCLA6 (UCLA BSCRC hESC Core) were maintained and expanded on irradiated primary mouse embryonic fibroblasts (EMD Millipore, Billerica, MA). All hPSC experiments were approved by the UCLA Embryonic Stem Cell Research Oversight (ESCRO) committee. Mesoderm commitment was induced as described previously (Evseenko et al., 2010; Hoffman and Calvi, 2014) 
+ embryonic mesoderm progenitors (hEMPs) were isolated by flow cytometry at day 3.5 ( Figure 1A ) and seeded onto Matrigel for mesenchymal differentiation over the next 14 days.
Mesenchymal Differentiation from hEMPs
To induce mesenchymal differentiation, hEMPs were seeded at 50,000 cells/well into 6-well tissue culture plates, pre-coated with Matrigel. Day 0-7 of differentiation, MesenCult Proliferation Kit, Human (STEMCELL Technologies) supplemented with SB-431542 (10 mM, R&D Systems) was used. Day 0-3, 10 mM Rock inhibitor (Y27632 hydrochloride; R&D Systems) and 10 mg/mL gentamicin (Gibco, Thermo Fisher Scientific, Waltham, MA) were also added. Day 7-14, medium was switched to EGM-2 (Lonza) supplemented with SB-431542 (10 mM). 
Graphical and Statistical Analysis
Graphs were generated and statistics analyzed using GraphPad Prism software. Paired parametric two-tailed t tests were used to calculate p values except in cases where normalized values were used, in which case unpaired parametric t tests were used. p < 0.05 was considered statistically significant.
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